Monkeypox DNA by PCR (Qualitative) at Chughtai Lab

Monkeypox DNA by PCR (Qualitative) at Chughtai Lab

The Monkeypox DNA by PCR (Qualitative) test at Chughtai Lab is a highly sophisticated molecular diagnostic assay designed to detect the presence of the Monkeypox virus (Mpox) genetic material in clinical specimens. Mpox is an infectious disease caused by the Monkeypox virus, a double-stranded DNA virus belonging to the Orthopoxvirus genus within the Poxviridae family. As public health concerns regarding Mpox transmission persist globally and within Pakistan, rapid, precise, and definitive diagnostic testing is paramount. This qualitative Polymerase Chain Reaction (PCR) test serves as the gold standard for confirming active infections, enabling timely clinical management, patient isolation, and effective outbreak control.

The technology behind this molecular test relies on real-time PCR (qPCR), which amplifies specific target sequences of the viral genome. By utilizing sequence-specific primers and fluorescently labeled probes, the assay can detect even minute quantities of viral DNA with exceptional sensitivity and specificity. Unlike serological tests, which detect antibodies that may only appear weeks after infection or cross-react with other orthopoxviruses (such as smallpox or varicella), the PCR assay directly identifies the pathogen's unique genetic signature. This minimizes the risk of cross-reactivity and provides definitive diagnostic clarity during the acute phase of the illness.

The primary anatomical targets for specimen collection are cutaneous or mucosal lesions, including vesicular fluid, pustules, dry scabs, or lesion crusts. Because the viral load is highly concentrated within these dermatological manifestations, swabbing the active lesions yields the highest diagnostic accuracy. The clinical importance of this test cannot be overstated; it allows healthcare providers to differentiate Mpox from other clinically similar rash-producing illnesses, such as chickenpox (varicella-zoster virus), shingles, herpes simplex, and hand-foot-and-mouth disease. Early diagnostic confirmation at Chughtai Lab ensures that patients receive appropriate supportive care while preventing unnecessary anxiety and secondary transmission within households and healthcare settings.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is essential to ensure specimen integrity and prevent false-negative or inconclusive results. Patients undergoing the Monkeypox DNA by PCR (Qualitative) test at Chughtai Lab should adhere to the following guidelines:

• No Topical Applications: Do not apply any topical creams, ointments, powders, lotions, or disinfectants to the active skin lesions for at least 24 hours prior to sample collection, as these substances can interfere with the PCR amplification process.
• Cleanliness: Keep the affected skin areas clean and dry. Avoid washing the lesions immediately before the test with harsh chemical soaps.
• Symptom Documentation: Prepare a brief history of your symptoms, including the date of rash onset, presence of fever, swollen lymph nodes, travel history, and any known contact with individuals suspected of having Mpox.
• Identification and Consent: Bring a valid government-issued identification card (such as a CNIC) and any referral letters from your physician. You may be asked to complete a brief epidemiological questionnaire.
• Protective Measures: Wear a well-fitting surgical mask or N95 respirator and ensure all skin lesions are fully covered with clothing or loose bandages when visiting the lab to prevent transmission to healthcare workers and other patients.

During the Procedure

The sample collection process is conducted under strict biosafety protocols to safeguard both the patient and the healthcare professional. Here is what you can expect during the procedure at Chughtai Lab:

• Biosafety Environment: The collection is performed in a designated, well-ventilated private room or a specialized isolation booth by a trained phlebotomist or laboratory technician wearing full Personal Protective Equipment (PPE), including an N95 mask, protective gown, face shield, and double gloves.
• Specimen Selection: The technician will select active, intact lesions (vesicles or pustules) for sampling. If multiple types of lesions are present on different parts of the body, samples may be taken from more than one site to maximize the diagnostic yield.
• Swabbing Technique: Using a sterile synthetic swab (such as Dacron or polyester), the technician will vigorously swab the base of the lesion or rub the fluid from an opened vesicle. While this may cause mild, temporary discomfort or stinging, a firm swab is necessary to collect adequate epithelial cells containing the viral DNA.
• Scab Collection: If the lesions have already crusted over, the technician may gently collect the scabs or crusts using sterile forceps and place them directly into a sterile collection tube.
• Packaging and Transport: The collected swabs are immediately placed into a viral transport medium (VTM) or a dry sterile tube, labeled with unique patient identifiers, and sealed in double-barrier biohazard packaging. The sample is then transported to Chughtai Lab's central molecular pathology department under controlled temperature conditions to preserve viral DNA.

When is a Monkeypox DNA by PCR (Qualitative) Performed?

Evaluation of Unexplained Acute Vesicular or Pustular Rash

Physicians request the Monkeypox PCR test when a patient presents with an unexplained, acute skin rash that progresses through sequential stages: macules, papules, vesicles, pustules, and eventually crusts. This characteristic dermatological progression is a hallmark of orthopoxvirus infections. Because these lesions can resemble other common dermatological conditions, the qualitative PCR test is critical to confirm whether the rash is caused by the Monkeypox virus, allowing for immediate clinical intervention and monitoring.

Assessment of Patients with Systemic Prodromal Symptoms

The onset of Mpox is frequently preceded by a prodromal phase characterized by systemic symptoms such as high fever, intense headache, myalgia (muscle aches), backache, profound asthenia (exhaustion), and lymphadenopathy (swollen lymph nodes). Lymphadenopathy is a key clinical feature that distinguishes Mpox from smallpox and chickenpox. When these systemic symptoms are followed by the appearance of even a single atypical lesion, clinicians order the PCR test to establish an early and accurate diagnosis.

Screening of High-Risk Contacts and Epidemiological Links

If an individual has had close, direct physical contact, intimate contact, or prolonged face-to-face exposure with a confirmed or suspected case of Mpox, they are at high risk of contracting the virus. In such cases, the development of any suspicious skin lesions or systemic symptoms warrants immediate PCR testing. Identifying positive cases among close contacts helps public health officials trace transmission chains and implement quarantine measures to prevent localized outbreaks in Pakistan.

Differential Diagnosis of Atypical Dermatological Eruptions

In patients with compromised immune systems, such as those with poorly controlled HIV or undergoing immunosuppressive therapies, Mpox can present atypically, with severe, confluent, or necrotic lesions. It can also co-exist with other sexually transmitted infections (STIs) or viral exanthems. Clinicians utilize the qualitative PCR test to rule out or confirm Mpox in complex clinical presentations, ensuring that the patient receives targeted antiviral therapies and appropriate wound care management.

Clinical Validation for Public Health and Isolation Protocols

For patients admitted to healthcare facilities with suspected infectious rashes, rapid diagnostic confirmation is essential for hospital infection control. A positive PCR result validates the necessity of strict airborne and contact isolation precautions, protecting vulnerable hospitalized patients and healthcare staff. Conversely, a negative result helps de-escalate isolation protocols, optimizing hospital resource allocation and improving patient comfort.

What Does a Monkeypox DNA by PCR (Qualitative) Detect?

The qualitative PCR test is designed to detect specific molecular and biological markers associated with the Monkeypox virus. The assay evaluates and identifies several critical parameters, including:

• Presence of highly conserved regions of the Monkeypox virus genome.
• Detection of viral DNA in vesicular or pustular fluid.
• Presence of viral genomic material within lesion crusts and scabs.
• Validation of specimen adequacy through human cellular internal controls (e.g., RNase P gene).
• Differentiation between Orthopoxvirus genus DNA and non-poxvirus pathogens.
• Identification of viral DNA in mucosal swabs (oropharyngeal or rectal), if clinically indicated.
• Absence of viral DNA, indicating a negative result for active Mpox infection.
• Detection of viral DNA in the early stages of lesion development.
• Presence of non-viable or fragmented viral DNA in healing lesions.
• Assay control verification to rule out the presence of PCR inhibitors in the sample.
• Clade-specific genetic sequences (Clade I or Clade II), depending on the specific multiplex assay utilized.
• Exclusion of Varicella-Zoster Virus (VZV) DNA when multiplexed.
• Exclusion of Herpes Simplex Virus (HSV-1 and HSV-2) DNA.
• Verification of sample collection quality based on epithelial cell yield.
• Detection of low-level viral shedding in resolving lesions.
• Confirmation of viral clearance in follow-up testing, if clinically required.
• Identification of potential sample contamination through negative control monitoring.
• Detection of viral DNA in atypical or localized lesions.
• Assessment of sample stability post-transportation to the molecular laboratory.
• Detection of genetic markers unique to the current circulating global strains of Mpox.

Turnaround Time and Report Access at Chughtai Lab

At Chughtai Lab, we understand that waiting for diagnostic results can be an anxious time for patients and their families. Because molecular testing requires meticulous preparation, DNA extraction, and amplification, the turnaround time for the Monkeypox DNA by PCR (Qualitative) test is typically 24 to 48 hours from the time the specimen reaches our central molecular pathology laboratory. This timeframe ensures that all quality control checks are thoroughly completed, minimizing the risk of false results.

Chughtai Lab offers seamless and convenient digital access to your diagnostic reports. Once your report is finalized and signed off by a consultant pathologist, you will receive an automated SMS and WhatsApp notification containing a direct link to download your report. Patients can also access their results online through the official Chughtai Lab website portal or via the Chughtai Lab mobile application, available for both iOS and Android platforms. For those who prefer physical copies, reports can be collected from any of our numerous collection centers conveniently located across major cities in Pakistan.

Monkeypox DNA by PCR (Qualitative) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Monkeypox Virus DNA	Not Detected (Negative)	Detected (Positive) – indicates active infection with Monkeypox virus.
Internal Control (RNase P)	Detected (Valid) – confirms adequate human cell collection and sample integrity.	Not Detected (Invalid) – indicates insufficient cellular material or PCR inhibition.
Cycle Threshold (Ct) Value	No Ct value observed (No amplification)	Low Ct value (high viral load) or High Ct value (low viral load / early or late stage).
Orthopoxvirus Genus Target	Not Detected (Negative)	Detected (Positive) – indicates infection with a member of the Orthopoxvirus genus.
Specimen Adequacy	Satisfactory – sufficient viral/cellular material present.	Unsatisfactory – sample must be recollected due to degradation or poor swabbing.
PCR Inhibitors	Absent – reaction proceeded without interference.	Present – substances in the sample blocked DNA amplification, requiring retesting.
Clade Differentiation (if performed)	Not Applicable	Clade I (associated with more severe disease) or Clade II (associated with the global outbreak).
Co-infection Markers (HSV/VZV)	Not Detected (Negative)	Detected (Positive) – indicates co-infection or alternative diagnosis of Herpes or Chickenpox.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient's symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Monkeypox DNA by PCR (Qualitative)?

• State-of-the-Art Molecular Pathology: Chughtai Lab utilizes advanced real-time PCR platforms and high-quality reagents to deliver exceptionally accurate and reliable results.
• ISO 15189 Certified Quality Standards: Our laboratories adhere to stringent international quality management systems, ensuring clinical excellence and diagnostic precision.
• Experienced Pathologists and Scientists: Your tests are processed and interpreted by highly qualified molecular biologists and consultant pathologists with extensive expertise in infectious disease diagnostics.
• Strict Biosafety and Infection Control: We maintain rigorous biosafety protocols during sample collection and processing to ensure patient safety and prevent cross-contamination.
• Convenient Home Sample Collection: To minimize public exposure, Chughtai Lab offers specialized home sample collection services by trained staff equipped with appropriate PPE.
• Rapid Turnaround Time: We prioritize critical infectious disease testing, ensuring that accurate results are delivered promptly to facilitate timely clinical decisions.
• Easy Digital Report Access: View and download your reports instantly via our user-friendly mobile app, website portal, WhatsApp, or SMS notifications.
• Extensive Network Across Pakistan: With hundreds of collection centers nationwide, Chughtai Lab provides accessible, high-quality diagnostic services to patients in Lahore, Karachi, Islamabad, and beyond.